Contemporary predictors of coronary artery disease in patients referred for angiography

Aims Risk stratification is often used to determine the need and priority for coronary angiography. We investigated the contemporary value of Framingham and SCORE risk models, individual risk factors, B-type natriuretic peptide and high-sensitivity C-reactive protein (hs-CRP) in the current era of intensive risk management. Methods and results Coronary artery disease (CAD) was obstructive (≥ 50% stenosis) in 328 of 539 patients referred for elective diagnostic coronary angiography (61%). Lower rates of smoking, more exercise and lower cholesterol were noted in those with angiographic CAD, compatible with risk factor modification in these patients. Framingham and SCORE were associated with CAD both in patients with and without prior cardiovascular disease (CVD). In multivariate analysis only age, male sex, diabetes, chest pain and prior CVD were independent predictors of CAD; odds ratio 1.74 per 10 years (95% confidence interval: 1.34-2.27), 5.48 (3.36-8.92), 2.57 (1.44-4.60), 1.69 (1.02-2.81) and 2.61 (1.65-4.12), respectively. Classification of disease was not improved by B-type natriuretic peptide or hs-CRP when added to conventional risk factors, although the latter seems to have value in patients without earlier CVD and low-density lipoprotein-cholesterol of less than 3.4 mmol/l; the adjusted odds ratio for hs-CRP ≥ 2 mg/l in this sub-group was 2.49 (1.12-5.51, P = 0.024). Conclusion Framingham and SCORE risk models can be used in clinical practice to predict angiographic coronary disease although risk factor modification limits the predictive value of smoking, blood pressure, lipid profiles and cardiac biomarkers. Eur J Cardiovasc Prev Rehabil 17:280-288 © 2010 The European Society of Cardiology

[1]  O. May,et al.  A high blood pressure predicts bleeding complications and a longer hospital stay after elective coronary angiography using the femoral approach. , 2009, Journal of interventional cardiology.

[2]  V. Somers,et al.  Abstract 4984: Trends in 10-year Risk of Incident Cardiovascular Disease in the United States, 1972-2004 , 2008 .

[3]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[4]  A. Einstein,et al.  Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. , 2007, JAMA.

[5]  S. Neubauer,et al.  Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group , 2007, Heart.

[6]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[7]  H. Rickli,et al.  Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease. , 2006, The American journal of cardiology.

[8]  L. Køber,et al.  Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease? , 2006, American heart journal.

[9]  R. Califf,et al.  Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. , 2005, JAMA.

[10]  H. Neuhauser,et al.  A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998 , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[11]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[12]  L. Wallentin,et al.  Natriuretic peptides in unstable coronary artery disease. , 2004, European heart journal.

[13]  E. Yeh CRP as a mediator of disease. , 2004, Circulation.

[14]  H. Crijns,et al.  Prognosis of atrial fibrillation in congestive heart failure. , 2004, Circulation.

[15]  M. Pepys,et al.  C-reactive protein and cardiovascular disease: new insights from an old molecule. , 2003, QJM : monthly journal of the Association of Physicians.

[16]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[17]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[18]  B. Horne,et al.  C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. , 2002, Journal of the American College of Cardiology.

[19]  S. Reis,et al.  Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). , 2001, The American journal of cardiology.

[20]  O. Morel,et al.  Global left ventricular cardiac function: comparison between magnetic resonance imaging, radionuclide angiography, and contrast angiography. , 1999, Investigative radiology.

[21]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[22]  K. Huber,et al.  Assessment of left ventricular function: comparison between radionuclide angiography and semiquantitative two-dimensional echocardiographic analysis , 1996, European Journal of Nuclear Medicine.

[23]  R. Krone,et al.  Five year trends in cardiac catheterization: a report from the Registry of the Society for Cardiac Angiography and Interventions. , 1996, Catheterization and cardiovascular diagnosis.

[24]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[25]  William Wijns,et al.  Relation Between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis , 1995 .

[26]  M. Emond,et al.  Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.

[27]  D. Wilcken,et al.  Determinants of severity of coronary artery disease in Australian men and women. , 1994, Circulation.

[28]  A. Hofman,et al.  Cardiovascular risk and all-cause mortality; A 12 year follow-up study in The Netherlands , 1993, European Journal of Epidemiology.

[29]  Robert Califf,et al.  Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery Disease , 1993, Annals of Internal Medicine.

[30]  R. Kronmal,et al.  Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. , 1986, Journal of the American College of Cardiology.

[31]  R. W. Brower,et al.  Coronary Artery Atherosclerosis: Severity of the Disease, Severity of Angina Pectoris and Compromised Left Ventricular Function , 1981, Circulation.

[32]  N. Paul,et al.  Perioperative β-Blockers : Use With Caution Perioperative β Blockers in Patients Having Non-Cardiac Surgery : A Meta-Analysis , 2010 .

[33]  G. Moneta,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .

[34]  A. Raftery Bayesian Model Selection in Social Research , 1995 .